Three Changes Have Finally Made EHR Evidence Underwriter-Grade

In a rapidly evolving healthcare data landscape, we explore EHR trends for underwriters and why these developments finally make EHR evidence underwriting-grade. For more than a decade Electronic Health Records (EHRs) have promised to improve efficiency in life insurance underwriting....

IWQOL-Lite-CT Implementation Options

IWQOL-Lite-CT© (Impact of Weight on Quality of Life-Lite-Clinical Trials) is the gold standard patient-reported outcome (PRO) measure of weight-related quality of life in adults designed for use in clinical trials. As the exclusive licensor of IWQOL-Lite-CT©, Greenlight works with CROs and biopharma organizations to implement the measure for regulated clinical trials.

Accelerating Clinical Trials: How Greenlight is Pioneering Change

Clinical trial sponsors are constantly seeking ways to accelerate study timelines, thereby more rapidly delivering therapeutics to patients and optimizing return on R&D investment. Accelerating clinical trials means acquiring high-quality data faster. It means developing protocols, configuring technology, activating research...

New FDA Policies Could Limit the Full Value of AI in Medicine 

The rapid advancement of artificial intelligence (AI) in medicine is paving the way for the potential development of artificial general intelligence (AGI), a revolutionary technology capable of understanding and solving complex medical problems with human-like proficiency. However, regulatory challenges, particularly...

We Need More Robust Post-Market Surveillance For Health Care AI

As AI and machine learning (ML) continue to transform health care, the importance of effective post-market surveillance mechanisms becomes clear. With nearly 1,000 AI-enabled medical devices approved as of 2024, ranging from predictive glucose monitors to AI-equipped smartwatches, there is...

Why data practices are key for pharma firms to engage patients

In a digital world, people are increasingly concerned about data privacy. The pharmaceutical industry is no exception. The growing importance of data privacy requires companies to prioritize effective patient consent and preference management. Personalized medicine, electronic health records, and an...